Mesenchymal stromal cells (MSCs) have gained immense attention over the past two
decades due to their multipotent differentiation potential and pro-regenerative and …

Acute graft-versus-host disease (GVHD) is a life-threatening complication that can develop
after allogeneic hematopoietic stem cell transplantation. In particular, the prognosis of …

The therapeutic efficacy of clinically applied mesenchymal stromal cells (MSCs) is limited
due to their injection into harsh in vivo environments, resulting in the significant loss of their …

Recently, we have reported that extracellular vesicles (EVs) from the bone marrow
mesenchymal stromal cells (BM-MSC) of aplastic anemia (AA) patients inhibit hematopoietic …

Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative therapy for
patients with a variety of malignant and non-malignant diseases. Despite its life-saving …

Mesenchymal stromal cells (MSCs) are used to treat infectious and immune diseases and
disorders; however, its mechanism (s) remain incompletely defined. Here we find that bone …

Abstract Background Mesenchymal stem cells (MSCs) are a heterogeneous group of
subpopulations with differentially expressed surface markers. CD146+ MSCs correlate with …

Mechanotransduction is the process by which physical force is converted into a biochemical
signal that is used in development and physiology; meanwhile, it is intended for the ability of …

Haploidentical donor stem cell transplantation (haplo-SCT) has made great advances in
recent decades. The granulocyte colony-stimulating factor (G-CSF)-and antithymocyte …

Hematopoietic stem cell (HSC) transplantation-based treatments are in different phases of
clinical development, ranging from current therapies to a promise in the repair and …